Liver Function Tests

• 

  Subject Areas on Research

  • 74-Year-Old Woman With Fatigue, Anorexia, and Abdominal Pain. 
  • A GWAS Study on Liver Function Test Using eMERGE Network Participants. 
  • A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. 
  • Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. 
  • Acute hepatitis due to epstein-barr virus in an immunocompetent patient. 
  • Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. 
  • Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum. 
  • Cardiohepatic interactions in heart failure: an overview and clinical implications. 
  • Children's liver chemistries vary with age and gender and require customized pediatric reference ranges. 
  • Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. 
  • Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH. 
  • Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults. 
  • Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults. 
  • Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program. 
  • Donor hepatic function: a factor in postreperfusion syndrome. 
  • Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. 
  • Drug rechallenge following drug-induced liver injury. 
  • Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial. 
  • Effect of cyclosporine on bile secretion in rats. 
  • Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens. 
  • Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI. 
  • Evaluation of an Abnormal Liver Panel After Liver Transplantation. 
  • Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants. 
  • Experience with reduced-size liver transplantation in infants and children. 
  • FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients. 
  • Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years. 
  • Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. 
  • Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. 
  • Granulomatous hepatitis associated with acute cytomegalovirus infection. 
  • HLA-B*35:01 and Green Tea-Induced Liver Injury. 
  • Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. 
  • Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? 
  • Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury. 
  • Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. 
  • Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal? 
  • Hyperammonemia in the ICU. 
  • In the clinic. Hepatitis C. 
  • Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. 
  • Kinetics of hepatitis C virus reinfection after liver transplantation. 
  • Laboratory profile of sickle cell disease: a cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. 
  • Liver biopsy. 
  • Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. 
  • Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. 
  • Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma. 
  • Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. 
  • Liver transplantation in an adolescent with acute liver failure from acute lymphoblastic leukemia. 
  • Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers. 
  • Magnetic resonance imaging and hepatic hemodynamics: correlation with metabolic function in liver transplantation candidates. 
  • Malfunction of the liver after transplantation: an analysis of potential risk factors. 
  • Marked transaminase elevation in anorexia nervosa. 
  • Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome. 
  • Monitoring liver safety in drug development: the GSK experience. 
  • Mucolipidosis II (I-cell disease) presenting as neonatal cholestasis. 
  • NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. 
  • Necrotizing enterocolitis in the asphyxiated full-term infant. 
  • New therapies for chronic hepatitis C virus infection. 
  • Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? 
  • Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. 
  • Observations on man in an oxygen-helium environment at 380 mm. Hg total pressure. I. Clinical. 
  • Organ donation and treatment of the multi-organ donor. 
  • Patient-specific factors affecting patient-controlled analgesia dosing. 
  • Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease. 
  • Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. 
  • Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma. 
  • Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101. 
  • Portal Steal Syndrome After Full-Size Deceased Donor Liver Transplantation. 
  • Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort. 
  • Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction). 
  • Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis. 
  • Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. 
  • Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver. 
  • Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis. 
  • Severe cholestasis related to intraconazole for the treatment of onychomycosis. 
  • Sirtuin-1 expression and activity is diminished in aged liver grafts. 
  • The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. 
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. 
  • The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. 
  • The pharmacokinetics of timegadine and two of its metabolites after multiple oral dosing, and the effects of concomitant administration of ibuprofen. 
  • The relationship between hepatitis B surface antigen and antibody and continued drug use in narcotic dependency: a randomized controlled study. 
  • Toll-Like Receptors -2, -3, -4 and -7 Expression Patterns in the Liver of a CLP-Induced Sepsis Mouse Model. 
  • Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. 
  • Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. 
  • Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances. 
  • [Influence of meat diet on the activity of seven hepatic enzymes in rats; increase of transaminases as an example of enzymatic adaptation]. 
• 

  Keywords of People

  • Buckley, Rebecca Hatcher, James Buren Sidbury Distinguished Professor Emeritus of Pediatrics, in the School of Medicine, Pediatrics, Allergy and Immunology
  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology